AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

MSN Sita 100mg/1000mg Tablet ER

Prescription Icon
Prescription Required

Marketer

MSN Laboratories

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview MSN Sita 100mg/1000mg Tablet ER

DiabetaComb 100mg/1000mg Extended-Release tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney failure and vision loss, potentially lowering heart attack and stroke risks. DiabetaComb 100mg/1000mg ER may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and other medications. Consuming it with meals minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise regimen is crucial for effective diabetes management; lifestyle choices significantly impact blood sugar control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential side effect when used with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for everyone. Inform your doctor about prior kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting treatment. Pregnant or lactating individuals should seek medical advice. Other medications can interact with DiabetaComb 100mg/1000mg ER; disclose all medications to ensure safety. Alcohol should be minimized due to its blood glucose-lowering effect. Your physician will monitor kidney function and blood glucose levels throughout treatment.

Uses of MSN Sita 100mg/1000mg Tablet ER

Managing type 2 diabetes

Major Benefits of MSN Sita 100mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without crushing, chewing, or breaking it. Consume the MSN Sita 100mg/1000mg Extended-Release tablet with food.

Common Side effects of MSN Sita 100mg/1000mg Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use MSN Sita 100mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume the MSN Sita 100mg/1000mg Extended-Release tablet with a meal.

How MSN Sita 100mg/1000mg Tablet ER works:

Sita 100mg/1000mg Extended-Release tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This dual-action combination optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with MSN Sita 100mg/1000mg extended-release tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Sita 100mg/1000mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sita 100mg/1000mg tablet likely poses a safety risk for breastfeeding individuals. Available human data indicates potential transfer of the medication into breast milk, with the possibility of adverse effects on the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use MSN Sita 100mg/1000mg Extended-Release tablets cautiously, as dose modification may be necessary. Severe kidney disease contraindicates the use of MSN Sita 100mg/1000mg Extended-Release tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverUNSAFE

The extended-release Sita 100mg/1000mg tablet likely presents a risk to individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.

What if you forget to take MSN Sita 100mg/1000mg Tablet ER :

Should you forget a dose of MSN Sita 100mg/1000mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About MSN Sita 100mg/1000mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on MSN Sita 100mg/1000mg Tablet ER

MSN Sita 100mg/1000mg Extended-Release tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of MSN Sita 100mg/1000mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
MSN Sita 100mg/1000mg ER tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to MSN Sita 100mg/1000mg Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol with MSN Sita 100mg/1000mg ER tablets is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis), is a potential side effect of MSN Sita 100mg/1000mg Tablet ER. This rare complication is more likely in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these symptoms, discontinue Sitagliptin + Metformin and seek immediate medical attention.
MSN Sita 100mg/1000mg Extended-Release tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
MSN Sita 100mg/1000mg ER tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to MSN Sita 100mg/1000mg Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and MSN Sita 100mg/1000mg ER tablets is unsafe and may raise your risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of MSN Sita 100mg/1000mg Tablet ER. This condition results from excessive blood lactic acid. Because it's rare, metformin use is avoided in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of MSN Sita 100mg/1000mg ER tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, supplemental vitamin B12 is recommended at least annually.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
MSN Sita 100mg/1000mg Extended-Release tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
MSN Sita 100mg/1000mg ER tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to MSN Sita 100mg/1000mg Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and MSN Sita 100mg/1000mg ER tablets is unsafe due to the increased risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of MSN Sita 100mg/1000mg Tablet ER. This is due to a buildup of lactic acid in the blood and is rare, but avoided in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of MSN Sita 100mg/1000mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
MSN Sita 100mg/1000mg Tab...
172